HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients

The inability of patients with CVID to mount specific antibody responses to pathogens has raised concerns on the risk and severity of SARS-CoV-2 infection, but there might be a role for protective T cells in these patients. SARS-CoV-2 reactive T cells have been reported for SARS-CoV-2 unexposed heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Steiner, Sophie, Sotzny, Franziska, Bauer, Sandra, Na, Il-Kang, Schmueck-Henneresse, Michael, Corman, Victor M., Schwarz, Tatjana, Drosten, Christian, Wendering, Désirée J., Behrends, Uta, Volk, Hans-Dieter, Scheibenbogen, Carmen, Hanitsch, Leif G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785785/
https://www.ncbi.nlm.nih.gov/pubmed/33424856
http://dx.doi.org/10.3389/fimmu.2020.607918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785785/
https://www.ncbi.nlm.nih.gov/pubmed/33424856
http://dx.doi.org/10.3389/fimmu.2020.607918

Ejemplares similares